- Home
- ZIP vs ALEC Comparison
ZIP vs ALEC Comparison
Compare ZIP & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZIP | ALEC |
|---|---|---|
| Founded | 2010 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 229.6M | 268.2M |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ZIP | ALEC |
|---|---|---|
| Price | $3.16 | $2.56 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 6 |
| Target Price | $3.88 | ★ $4.83 |
| AVG Volume (30 Days) | ★ 736.3K | 444.2K |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $448,952,000.00 | $21,045,000.00 |
| Revenue This Year | $1.00 | $2.03 |
| Revenue Next Year | $5.93 | $29.87 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.65 | $0.98 |
| 52 Week High | $6.55 | $3.40 |
Technical Indicators
Market Signals| Indicator | ZIP | ALEC |
|---|---|---|
| Relative Strength Index (RSI) | 66.00 | 58.48 |
| Support Level | $1.68 | $1.89 |
| Resistance Level | $4.85 | $2.60 |
| Average True Range (ATR) | 0.20 | 0.17 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 94.48 | 68.77 |
Price Performance
Historical ComparisonAbout ZIP ZipRecruiter Inc.
ZipRecruiter Inc is an online employment marketplace that connects job seekers and employers through an AI-powered platform. The company provides recruiting solutions that help employers identify and hire qualified candidates while enabling job seekers to discover relevant job opportunities through intelligent matching and recommendation tools.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.